CoQ10 in Patients with Nonalcoholic Fatty Liver Disease

Non-alcoholic fatty liver disease is the most common cause of chronic liver injury.  After 4 weeks of CoQ10 supplementation, waist circumference and serum AST concentrations were significantly decreased as compared to the placebo-treated group.  The study showed a potential for CoQ10 therapy in improving serveral anthropometric and biochemical variables in non-alcoholic fatty liver disease.  Longer studies…

Read More

L-carnitine Reduces Muscle Cramps in Patients With Cirrhosis

April 6, 2015 This December  9, 2014 article from Clinical Gastroenterology Hepatology evaluated a prospective study to evaluate L-carnitine, which is involved in the beta-oxidation of fatty acids, to reduce muscle cramps in patients with cirrhosis.  They were given L-carnitine 300mg, 3 times a day or 4 times a day for 8 weeks.  Muscle cramps…

Read More

Can Cirrhotic Livers Regenerate?

November 26, 2014 The regeneration of normal and cirrhotic liver has been very well demonstrated after partial hepatectomy; although the tissue regenerated by cirrhotic liver is also cirrhotic.  The structural differences of the regenerated tissues between normal and cirrhotic livers may also indicate different regeneration capacities.  In this rat study, cirrhotic livers revealed a significantly…

Read More